Longevity is the beauty industry’s most powerful claim—and its weakest link

Résumé détaillé

That gap is where the credibility problem begins.

Longevity has become the beauty industry’s most powerful claim and its most consequential bet. The industry is selling something far more ambitious than anti-aging: the idea that skincare can intervene in the biology of aging itself. It transcends an evolution of marketing language; it’s a structural shift that changes how beauty is researched, organized, priced, and, ultimately, who gets to own the category.

L’Oréal and Estée Lauder are shifting their focus from anti-aging skincare to longevity, positioning aging as a biological process that can be measured and influenced, but pursuing different strategies.

L’Oréal’s strategy is broad and data-driven. Its Longevity Integrative Science platform is anchored by its proprietary Longevity AI Cloud ™, which the company says analyzes over 260 biomarkers using a framework of twelve hallmarks of aging to predict how ingredients affect skin biology. L’Oréal applied this research to its Cell BioPrint Skin Age Test and Lancôme Absolue Longevity products. It pairs DNA-derived ingredients such as PDRN with mitochondrial repair claims.

Estée Lauder’s strategy is narrower, luxury-led and built on proprietary research and clinical studies. Its Skin Longevity Institute focuses sirtuin biology, energy-boosting delivery systems and academic collaborations. It repositioned Re-Nutriv around its SIRTIVITY-LP™ technology, based on over 40 patents, and claims improvements in visible skin age, citing two peer-reviewed clinical papers examining a skincare regimen and a facial age assessment model.

Across the market, brands are converging on the same premise: skincare can influence how skin ages at the cellular level. Luxury moved first with the most conviction. Guerlain promises measurable gains in cellular vitality. Tatcha reframes barrier health as long-term cellular performance.

Mass and clinical brands are following suit. Nivea promotes epigenetic “resetting.” OneSkin claims to reduce biological age by targeting senescent cells.

Ingredient…

In…

Début de l'article, extrait de Fortune. Pour lire la suite, ouvrez l'article chez le média.